A major discovery in cancer investigation is occurring with the use of nanobodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently inactivated in several types of malignancies, leading https://sociallweb.com/story7519093/mini-antibodies-revive-the-p53-protein-the-new-approach-for-malignant-treatment